Covid-19: Single dose of Pfizer and Oxford vaccines cuts risk of hospital admission by 80% in over 80s, data suggest
Covid-19: Single dose of Pfizer and Oxford vaccines cuts risk of hospital admission by 80% in over 80s, data suggest – The BMJ Commentary on Twitter Both the Pfizer BioNTech and the Oxford AstraZeneca vaccines are highly effective in reducing covid-19 infections and protecting against severe disease in older adults, preliminary data show https://t.co/THSv5kiIVt […]
The post Covid-19: Single dose of Pfizer and Oxford vaccines cuts risk of hospital admission by 80% in over 80s, data suggest appeared first on Links Medicus.
More transmissible and evasive SARS-CoV-2 variant growing rapidly in Brazil
More transmissible and evasive SARS-CoV-2 variant growing rapidly in Brazil – Imperial College London Original study (preprint): Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil Commentaries: Covid Brazil variant ‘may spread more easily’ – BBC AND Brazil coronavirus variant: what is it and why is it a concern? An expert explains – The […]
The post More transmissible and evasive SARS-CoV-2 variant growing rapidly in Brazil appeared first on Links Medicus.
NIH halts trial of COVID-19 convalescent plasma in emergency department patients with mild symptoms
NIH halts trial of COVID-19 convalescent plasma in emergency department patients with mild symptoms – National Institutes of Health
The post NIH halts trial of COVID-19 convalescent plasma in emergency department patients with mild symptoms appeared first on Links Medicus.
WHO Guideline recommends against Hydroxychloroquine to prevent Covid-19
A living WHO guideline on drugs to prevent covid-19 – The BMJ See also: WHO Living guideline: Drugs to prevent COVID-19 – World Health Organization Commentaries: WHO advises against hydroxychloroquine to curb COVID-19 – CIDRAP AND WHO panel issues strong advice against hydroxychloroquine for COVID-19 – Reuters Commentary on Twitter The anti-inflammatory drug hydroxychloroquine […]
The post WHO Guideline recommends against Hydroxychloroquine to prevent Covid-19 appeared first on Links Medicus.
The predicative clinical features associated with chronic cough that has a single underlying cause
The Predicative Clinical Features Associated with Chronic Cough That Has a Single Underlying Cause – The Journal of Allergy and Clinical Immunology: In Practice News release: Clinical features for indicating causes of chronic cough – American Academy of Allergy, Asthma & Immunology
The post The predicative clinical features associated with chronic cough that has a single underlying cause appeared first on Links Medicus.
M-A: Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults
Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis – PLOS Medicine
The post M-A: Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults appeared first on Links Medicus.
Systematic Review: Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19 – Cochrane Library Summary: Can symptoms and medical examination accurately diagnose COVID-19? – Cochrane Library We’ve updated our review on signs and symptoms for diagnosing Covid-19. Now includes evidence on loss of smell or taste #redflag […]
The post Systematic Review: Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19 appeared first on Links Medicus.
Studies: Secondary infections in patients with severe COVID-19
Secondary Infections in Patients with Severe COVID-19 – NEJM Journal Watch Study 1: Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome – Intensive Care Medicine Study 2: COVID-19 increased the risk of ICU-acquired bloodstream infections: a case–cohort study from the multicentric OUTCOMEREA network – Intensive Care Medicine
The post Studies: Secondary infections in patients with severe COVID-19 appeared first on Links Medicus.
Serious bradycardia and Remdesivir for COVID-19: a new safety concern
Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns – Clinical Microbiology and Infection Commentary on Twitter ⛔A new safety concern⛔New ? post-marketing study @CMIJournal suggests that the use of remdesivir is significantly associated with an increased risk of reporting serious bradycardia compared with HCQ,LPV/RTV, tocilizumab or glucocorticoids #IDTwitter https://t.co/npLMchifEM — […]
The post Serious bradycardia and Remdesivir for COVID-19: a new safety concern appeared first on Links Medicus.
Review: Cardiovascular biomarkers in patients with COVID-19
Cardiovascular biomarkers in patients with COVID-19 – European Heart Journal. Acute Cardiovascular Care Commentary on Twitter Cardiovascular #biomarkers in patients with #COVID19 – review article by @escardio Study Group on Biomarkers in Cardiology of the Acute Cardiovascular Care Association #ACVC_ESC https://t.co/9Mcx24fX8y#EHJACVC #cardiotwitter #medtwitter pic.twitter.com/y7kD2Oylrj — European Society of Cardiology Journals (@ESC_Journals) March 1, 2021 […]
The post Review: Cardiovascular biomarkers in patients with COVID-19 appeared first on Links Medicus.